Skip to main content
Nicole Balmaceda, MD, Internal Medicine, Aurora, CO

NicoleBalmacedaMD(She/Her)

Internal Medicine Aurora, CO

Hematology/Oncology

Hematology/Oncology Fellow Physician

Dr. Balmaceda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Balmaceda's full profile

Already have an account?

  • Office

    12801 East 17th Avenue 8122
    Aurora, CO 80045
    Phone+1 913-588-3974
    Fax+1 913-588-0593

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Hematology and Medical Oncology, 2022 - 2025
  • University of Kansas School of Medicine
    University of Kansas School of MedicineResidency, Internal Medicine, 2019 - 2022
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 2019, KUMC Research Institute GI Cancer Research Award
  • University of Kansas
    University of KansasBS, Biochemistry, Heidi Everley Research Award, 2011 - 2015

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2019 - 2022
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care  
    Nicole Balmaceda, American Society of Clinical Oncology Educational Book, 5/21/2024
  • Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) cohort study  
    Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bod..., eLife, 10/17/2023
  • Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19  
    Ziad Bakouny, MD; Chris Labaki, MD; Punita Grover, MD; et al, JAMA Oncology, 11/3/2022
  • Join now to see all

Abstracts/Posters

  • Effect of durable hematocrit control and minimal thrombotic risk in real-world polycythemia vera patients treated with ruxolitinib.
    Aleksander Lech Chojecki, Danielle Boselli, Allison Dortilus, Issam Hamadeh, Stephanie Begley, Tommy Chen, Rupali Bose, Nikolai Alexandrovich Podoltsev, Amer Methqal Z..., Journal of Clinical Oncology , 2023 ASCO, 6/1/2023

Professional Memberships

  • American Association for Cancer Research
    Member
  • American College of Physicians
    ACP Council Student Representative
  • American Medical Association
    Member
  • American Society of Clinical Oncology
    Member
  • European Society of Medical Oncology
    Member